FDAnews
www.fdanews.com/articles/147554-vertex-more-evidence-cystic-fibrosis-combo-therapy-improves-lung-function

Vertex: More Evidence Cystic Fibrosis Combo Therapy Improves Lung Function

June 28, 2012
Vertex Pharmaceuticals’ two-drug therapy significantly improved lung function in patients with the most common genetic mutation causing cystic fibrosis, according to final results from a mid-stage study announced Thursday.
The Street